The antiviral action of restriction factors like CIITA and ZAP, targeting both HTLV-1 replication and oncogenesis, could aid in designing molecular targets for the prevention of ATLL. The gene discussed is ZC3HAV1; the disease is adult T-cell leukemia/lymphoma.